Multimodal Treatment Plans in Prostate Cancer

Rachel Lin Flanagan; Jeffrey John Tomaszewski

doi:10.1007/978-3-030-52021-2_5

Multimodal Treatment Plans in Prostate Cancer

Rachel Lin Flanagan
, Jeffrey John Tomaszewski

CMSRU Faculty Affairs

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

There are a variety of options that can be utilized in the detection, prevention, and treatment of prostate cancer. This chapter focuses specifically on postoperative radiotherapy and its use in both the adjuvant and salvage setting following radical prostatectomy. Indications for the utilization of prostate cancer genomic biomarkers are also reviewed. The utility of genomic biomarkers in prostate cancer early diagnosis and long-term outcomes are discussed. Finally, the ability of biomarkers to influence management decisions and assist in the prevention of overtreatment is explored.

Original language	English (US)
Title of host publication	Chemotherapy and Immunotherapy in Urologic Oncology
Subtitle of host publication	a Guide for the Advanced Practice Provider
Publisher	Springer International Publishing
Pages	43-53
Number of pages	11
ISBN (Electronic)	9783030520212
ISBN (Print)	9783030520205
DOIs	https://doi.org/10.1007/978-3-030-52021-2_5
State	Published - Jan 1 2020

All Science Journal Classification (ASJC) codes

General Medicine

Access to Document

10.1007/978-3-030-52021-2_5

Cite this

@inbook{4848c3e461e0474fa0697e9cbe53e779,

title = "Multimodal Treatment Plans in Prostate Cancer",

abstract = "There are a variety of options that can be utilized in the detection, prevention, and treatment of prostate cancer. This chapter focuses specifically on postoperative radiotherapy and its use in both the adjuvant and salvage setting following radical prostatectomy. Indications for the utilization of prostate cancer genomic biomarkers are also reviewed. The utility of genomic biomarkers in prostate cancer early diagnosis and long-term outcomes are discussed. Finally, the ability of biomarkers to influence management decisions and assist in the prevention of overtreatment is explored.",

author = "Flanagan, \{Rachel Lin\} and Tomaszewski, \{Jeffrey John\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2021.",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/978-3-030-52021-2\_5",

language = "English (US)",

isbn = "9783030520205",

pages = "43--53",

booktitle = "Chemotherapy and Immunotherapy in Urologic Oncology",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Multimodal Treatment Plans in Prostate Cancer

AU - Flanagan, Rachel Lin

AU - Tomaszewski, Jeffrey John

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2021.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - There are a variety of options that can be utilized in the detection, prevention, and treatment of prostate cancer. This chapter focuses specifically on postoperative radiotherapy and its use in both the adjuvant and salvage setting following radical prostatectomy. Indications for the utilization of prostate cancer genomic biomarkers are also reviewed. The utility of genomic biomarkers in prostate cancer early diagnosis and long-term outcomes are discussed. Finally, the ability of biomarkers to influence management decisions and assist in the prevention of overtreatment is explored.

AB - There are a variety of options that can be utilized in the detection, prevention, and treatment of prostate cancer. This chapter focuses specifically on postoperative radiotherapy and its use in both the adjuvant and salvage setting following radical prostatectomy. Indications for the utilization of prostate cancer genomic biomarkers are also reviewed. The utility of genomic biomarkers in prostate cancer early diagnosis and long-term outcomes are discussed. Finally, the ability of biomarkers to influence management decisions and assist in the prevention of overtreatment is explored.

UR - https://www.scopus.com/pages/publications/105018257017

UR - https://www.scopus.com/pages/publications/105018257017#tab=citedBy

U2 - 10.1007/978-3-030-52021-2_5

DO - 10.1007/978-3-030-52021-2_5

M3 - Chapter

AN - SCOPUS:105018257017

SN - 9783030520205

SP - 43

EP - 53

BT - Chemotherapy and Immunotherapy in Urologic Oncology

PB - Springer International Publishing

ER -

Multimodal Treatment Plans in Prostate Cancer

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this